Regulation of production of soluble Fc gamma receptors type III in normal and pathological conditions.

[1]  S. Roman-Roman,et al.  Identification of the cleavage site involved in production of plasma soluble Fc gamma receptor type III (CD16) , 1998, European journal of immunology.

[2]  P. J. Middelhoven,et al.  Involvement of a metalloprotease in the shedding of human neutrophil FcγRIIIB , 1997 .

[3]  R. Bataille,et al.  Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells. , 1997, Blood.

[4]  S. Roman-Roman,et al.  A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells. , 1997, Cytokine.

[5]  K. Anderson,et al.  Interaction of tumor and host cells with adhesion and extracellular matrix molecules in the development of multiple myeloma. , 1997, Hematology/oncology clinics of North America.

[6]  R. Schmidt,et al.  IgG Binding Sites on Human FCγ Receptors , 1997 .

[7]  J. Galon,et al.  Soluble Fcγ Receptors: Interaction with Ligands and Biological Consequences , 1997 .

[8]  E. Tartour,et al.  Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS) , 1996, British journal of haematology.

[9]  J. Galon,et al.  Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors. , 1996, Journal of immunology.

[10]  E. Tartour,et al.  A transforming growth factor beta-like immunosuppressive factor in immunoglobulin G-binding factor , 1995, The Journal of experimental medicine.

[11]  C. Owen,et al.  Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases , 1995, The Journal of cell biology.

[12]  T G Wolfsberg,et al.  ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell- matrix interactions , 1995, The Journal of cell biology.

[13]  I. Maridonneau-Parini,et al.  The src-family protein-tyrosine kinase p59hck is located on the secretory granules in human neutrophils and translocates towards the phagosome during cell activation. , 1995, The Biochemical journal.

[14]  A. Verhoeven,et al.  Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. , 1995, Blood.

[15]  B. Barlogie,et al.  Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16. , 1995, The Journal of clinical investigation.

[16]  N. Hogg,et al.  Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. , 1994, Journal of immunology.

[17]  M. Ernst,et al.  Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo , 1994, Clinical and experimental immunology.

[18]  A. Barrett.  [1] Classification of peptidases , 1994 .

[19]  J. Galon,et al.  Soluble CD16 binds peripheral blood mononuclear cells and inhibits pokeweed-mitogen-induced responses. , 1993, Blood.

[20]  M. Tosi,et al.  Surface expression of Fc gamma receptor III (CD16) on chemoattractant-stimulated neutrophils is determined by both surface shedding and translocation from intracellular storage compartments. , 1992, The Journal of clinical investigation.

[21]  J. Nuijens,et al.  Soluble Fc gamma receptor III in human plasma originates from release by neutrophils. , 1990, The Journal of clinical investigation.

[22]  B. Perussia,et al.  Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions , 1989, The Journal of experimental medicine.

[23]  S. Weiss.  Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[24]  M. Berger,et al.  Functional differences between the 40 kDa and 50 to 70 kDa IgG Fc receptors on human neutrophils revealed by elastase treatment and antireceptor antibodies. , 1988, Journal of immunology.

[25]  T. Springer,et al.  The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria , 1988, Nature.